Loading...
Loading...
Below are the top diagnostic substances stocks on the NASDAQ in terms of return on investment.
The trailing-twelve-month return on investment at Nymox Pharmaceutical
NYMX is 73.80%. Nymox Pharmaceutical's revenue for the same period is $3.30 million.
The trailing-twelve-month return on investment at Meridian Bioscience
VIVO is 24.50%. Meridian Bioscience's EPS for the same period is $0.88.
The trailing-twelve-month return on investment at IDEXX Laboratories
IDXX is 20.20%. Laboratories' PEG ratio is 2.59.
The trailing-twelve-month return on investment at SurModics
SRDX is 13.60%. SurModics' profit margin for the same period is 23.20%.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in